iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
FDA clearance is permission for a specific AI medical device to be marketed for the intended use reviewed by the agency—not a guarantee that the software is universally accurate, predicts one person’s future, or replaces an oncologist. For a 510(k)-cleared device, the FDA’s central finding is substantial equivalence to a legally marketed predicate, supported by appropriate safety and performance information.
That distinction matters because an AI recurrence score is a prognostic estimate. It can add risk information for a defined patient group, but clearance alone does not show that changing chemotherapy, endocrine therapy, radiation, or surveillance on the basis of the score improves an individual patient’s outcome.
What the FDA actually cleared
The FDA regulates a medical device and its labeled intended use, not “AI” as an abstract technology. A clearance therefore applies to the named product, the patients it covers, the data it accepts, the outcome it estimates, and the role it is allowed to play in care.
510(k) clearance is a comparative decision
Most current examples discussed as AI breast-cancer recurrence tests use the 510(k) pathway. The manufacturer must show that the device is substantially equivalent to a legally marketed predicate device. The submission includes safety and performance information appropriate to the device and its use. The FDA describes the distinction this way: “The 510(k) review standard is comparative, whereas the PMA standard relies on an independent demonstration of safety and effectiveness.”
#1 Best Overall
- Powerful Turbo Fan:CAGIWIRU Electric Air Duster have reached speed up to 130000RPM,Can efficient remove dust and debris.With LED light and Three Adjustable Speed to meet with different cleaning tasks.
- With Attached USB C Fasting Charging cable.Charing 3 hours,Enjoy up to 240 minutes of use on the lowest setting, For third speed can use for 25mins.with four charging options to meet with your needs.
- Wide Application: attached 5 different nozzles,making it suitable for a variety of scenes, such as car,pet, pc, keyboards, and other electronic devices. It also serves for office and home clean duster.
- Handy Design & Portable:Cordless air duster electric nozzle is Light weight and small size, design and comfortable to hold and space saving, convenient to carry around. You can put it in your room or inside the car without taking up space.
- Economical &Reusable: Built durable materials with a long-lasting battery,our CAGIWIRU air duster it's a sustainable alternative to disposable air cans.
Substantial equivalence does not mean the new software and the predicate are identical. It means the FDA found no new questions of safety or effectiveness that require the more extensive premarket-approval route, given the comparison and supporting evidence. It also does not mean the software has been proven to improve survival or to make treatment decisions correctly for every patient.
Clearance is not the same as approval
In everyday conversation, people often call any FDA marketing authorization “approval.” In regulatory terms, the pathways differ:
- 510(k) clearance: authorization based on substantial equivalence to a legally marketed predicate plus supporting safety and performance information.
- De Novo classification: a route for certain novel, low- or moderate-risk devices when there is no suitable predicate. A De Novo device can establish a new classification and become a predicate for later 510(k) submissions.
- Premarket approval (PMA): the pathway for high-risk devices, requiring an independent demonstration of safety and effectiveness rather than the comparative 510(k) standard.
As of September 2026, the FDA said it had authorized more than 1,600 AI-enabled medical devices for marketing in the United States. That broad count includes many specialties and device types; it is not a count of breast-cancer recurrence tests and does not tell you how strong the evidence is for any particular product.
Recommended Free Tools
Why the labeled indication controls the meaning
To interpret an AI result, read the indication as a set of boundaries rather than as a general claim that the algorithm “finds cancer coming back.” Four details are decisive:
- Population: stage, receptor status, sex, age range, and whether the disease is invasive or noninvasive.
- Inputs: MRI images, digitized pathology slides, tumor tissue, clinical variables, or a combination.
- Endpoint: recurrence-free survival, distant metastasis, or another defined outcome over a stated period.
- Role in care: a prognostic indicator used alongside clinicopathologic factors, not an autonomous diagnosis or treatment order.
A prognostic score estimates risk for a group of patients with similar characteristics. It does not prove that a recurrence will or will not happen in one person. Nor does it show that a therapy selected because of the score will work better than an alternative. Stage, grade, biomarkers, treatment history, competing health risks, and the patient’s preferences remain part of the decision.
Two FDA-cleared examples are not the same test
TumorSight Risk
On October 15, 2026, SimBioSys announced FDA clearance of TumorSight Risk through 510(k). The company says its cloud software analyzes routinely collected breast MRI, pathology, and clinical data. It returns a score from 0 to 100 and assigns a low-, intermediate-, or high-risk category.
Rank #2
- Screen Cleaner is Your Screen’s New Bestfriend! - EVEO is proud to present a screen cleaner that’s perfectly suited for your TV. Meet your new screen cleaner, computer screen cleaner, laptop cleaner, iPad cleaner, Macbook,tv cleaner or any other electronic device. Our screen cleaner spray and wipe along with the included plush microfiber cloth, easily removes dust, fingerprints & other smudges on the screen’s surface. Clean effectively for a streak-free screen
- Gentle on your Screens - Our screen cleaner spray and wipes is compatible to be used even for the most sensitive LCD, LED, CRT, and OLED screens in proper use. Be at ease knowing that this product is compatible with all the major brands: LG, SONY, Samsung, Sharp, iPad, iPhone, Android screens, Kindle, PC monitors - we’ve got you covered! Can be used as LCD screen cleaner, tv cleaner, smart tv screen cleaner, and more
- Premium Super Soft Plush Microfiber Cloth - Included in this efficient screen cleaning kit. This screen cleaner spray and wipe has our signature plush microfiber cloth specially designed to comply with screens and monitors and leave them streak-free. Has been shown to effectively absorbs stubborn stains, zero streaks, and no fiber shedding. Always use this together with our screen cleaner for the best results
- Easy-to-Use Screen Cleaner Kit + microfiber cleaning cloth - The EVEO Screen Cleaning Kit will easily be your new favorite tool when it comes to taking care of the things you love most, quick and easy solution for a streak-free screen. Simply screw on the sprayer gun on the screen cleaner bottle. Spray the cleaning liquid onto the microfiber cloth, then wipe the screen until desired cleanliness & shine is achieved.
- Quality Screen Care Kit Worth Purchasing - Enjoy a convenient Screen Cleaner anytime, anywhere you need it. Your satisfaction is our top priority. We stand behind the quality of our products and that’s why, you shouldn’t be worrying at all. We manufacture the Best Screen Cleaner. and can be used for laptop cleaning kit, laptop screen cleaner, tv screen cleaner for smart tv. MacBook screen cleaner, monitor cleaner or screen cleaner spray for electronic devices with microfiber cleaning cloth
The stated intended use is as a prognostic indicator of recurrence-free survival at five and ten years in adult women with hormone-receptor-positive (HR-positive), HER2-negative stage I through IIIA breast cancer. Results are intended to be considered with other clinicopathologic factors.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →SimBioSys reports a blinded, prospectively designed retrospective, multi-institutional validation involving 2,129 patients from Mayo Clinic, Emory University, Stanford Medicine, and Mercy Medical Cedar Rapids. In the company’s report, the high-risk group had 3.3 times the recurrence risk of the low-risk group. Each 10-point increase in the score was associated with a 22% relative increase in recurrence risk. Estimated five-year recurrence risk ranged from 2.2% for scores of 0–10 to 13.6% for scores of 58–100; estimated ten-year risk ranged from 6.2% to 34.2% across those reported score groups.
Those performance figures are reported by SimBioSys. They should be read as company-reported results until the complete peer-reviewed evidence and the FDA decision summary are available for independent review.
ArteraAI Breast
On May 6, 2026, Artera announced FDA clearance of ArteraAI Breast for early-stage HR-positive, HER2-negative invasive breast cancer. Artera says the tool combines digitized histopathology images with clinical variables to stratify the risk of distant metastasis into low- and high-risk groups.
That is a different data modality and endpoint from TumorSight Risk. One uses MRI, pathology, and clinical data to estimate recurrence-free survival at five and ten years; the other uses digital pathology and clinical variables to classify distant-metastasis risk. The phrase “FDA-cleared AI recurrence test” therefore does not identify one universal product or one interchangeable score.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteAt-a-glance comparison
| Device | Stated population | Input data | Endpoint and output | Validation or evidence described | Workflow and clinical utility |
|---|---|---|---|---|---|
| TumorSight Risk | Adult women with HR-positive, HER2-negative stage I–IIIA breast cancer | Routinely collected breast MRI, pathology, and clinical data | 0–100 score; low, intermediate, or high category; prognostic indicator of five- and ten-year recurrence-free survival | Blinded, prospectively designed retrospective, multi-institutional validation of 2,129 patients at Mayo Clinic, Emory University, Stanford Medicine, and Mercy Medical Cedar Rapids; performance figures reported by SimBioSys | Cloud software; use alongside other clinicopathologic factors. Turnaround details were not stated in the October 15, 2026 announcement. |
| ArteraAI Breast | Early-stage HR-positive, HER2-negative invasive breast cancer | Digitized histopathology images and clinical variables | Low- or high-risk stratification for distant metastasis | Artera announced FDA clearance on May 6, 2026; the announcement describes the indication and modality but does not provide a comparable cohort size or risk percentages in the information summarized here | Digital pathology workflow; turnaround details and proof that treatment changes improve outcomes were not stated in the May 6, 2026 announcement. |
How to interpret a TumorSight Risk number
The score scale is continuous, while the reported categories group patients into broader risk bands. A score of 10 is not a promise of a 10% recurrence probability, and a score of 60 is not a diagnosis of recurrence. The reported percentages are estimated risks for the company’s validation groups and time horizons.
Rank #3
- 【Large size】：Measuring 800 x 300 mm/ 31. 5×12 inches, which is wider and taller than others. Large mouse pad can perfectly fit your keyboard and mouse of any size, and there is also ample space for peripherals such as phones, tablets, etc.
- 【LED backlight mouse pad】：Blade Hawks RGB mouse pad provides 7 static modes and 7 dynamic modes will give you the options you are looking for. Power-off memory function remembers the last lighting mode you selected. The super glow fiber Chroma will give you a colorful gaming setup that you want.
- 【Anti-slip rubber base】：Made from Natural rubber, this gaming mousepad will firmly grip your desktop, allowing you to enjoy the ultimate precision in the games you are most passionate about. It also comes with a texture that enhances this ability even further.
- 【Smooth and waterproof surface】: Micro-textured cloth surface, for extremely precise mouse control and a smooth movement. When liquid splashes on the gaming mouse pad, it forms water droplets and slides down. Will not delay your work or gameplay.
- 【Plug and play】: This mouse and keyboard pad is powered by USB, plug and play, no driver required. One button control light modes. Press one time to change the lighting mode, press twice to change the brightness, press and hold about 3 seconds turn ON/OFF.
For example, SimBioSys reports estimated five-year recurrence risk of 2.2% for scores from 0 to 10 and 13.6% for scores from 58 to 100. The corresponding ten-year estimates are 6.2% and 34.2%. These are absolute risk estimates for the defined study population; they are different from the reported 22% relative increase associated with each 10-point rise. Relative and absolute risk answer different questions, so ask your clinician which measure is being used in a treatment discussion.
The 3.3-fold difference between the reported high- and low-risk groups describes separation between groups. It does not mean that every high-risk patient will recur or that every low-risk patient is protected. Individual risk can differ because of tumor features, treatment received, adherence, other illnesses, and factors not represented in the model.
Clearance versus clinical utility
Regulatory clearance answers whether the device met the requirements of its pathway for its labeled use. Clinical utility asks a different question: does using the result to make a specific decision lead to better outcomes than the usual approach?
Free tools Windows power users keep installed
One-click scans. No signup required.
A validation can show that a score separates people with higher and lower observed risk without showing that clinicians should escalate or de-escalate treatment on the basis of that score. Evidence of utility would need to connect test-guided decisions with outcomes such as recurrence, survival, treatment complications, quality of life, or a reduction in unnecessary therapy. The clearance announcements summarized here do not establish that changing treatment according to either AI tool improves survival.
When discussing a result, separate three claims:
- Prognostic claim: the score is associated with an outcome in a defined population.
- Predictive claim: the score identifies who benefits more from one treatment than another.
- Action claim: using the score to change care improves outcomes.
FDA clearance of a prognostic device does not automatically establish the second or third claim.
How these tools compare with genomic recurrence assays
The National Cancer Institute explains that multigene assays analyze gene activity in tumor tissue. Depending on the assay and population, they may help estimate the chance of spread or recurrence and inform treatment decisions. NCI lists Oncotype DX, which analyzes 21 genes; MammaPrint, which analyzes 70 genes; and Breast Cancer Index, which analyzes 11 genes. Each has its own intended population and decision context.
Rank #4
- 【Softer and More Comfortable】Vaydeer wrist rest has unique diamond pattern, which is the combination of softness and aesthetics. The materials of wrist rest are improved into higher quality memory foam and covered with silky smooth lycra. The computer wrist rest makes you as comfortable and cushiony as like rest your wrists on clouds.
- 【Ergonomic Wrist Saver】The wrist rests for keyboard and mouse comes with a 17.32×3.15×0.83 inch keyboard wrist pad and a 5.94×3.15×0.83 inch mouse wrist support. Based on ergonomic design, the unique concave shape is the perfect fit for your wrist joints. The wrist rest pad fits most computer keyboards and laptops, improve hand and wrist posture, release your wrist and arm stress.
- 【Non-Slip Rubber Bottom】Featuring an anti-skid silicone base on the bottom, this wrist keyboard support stays firmly in place on your desk, preventing the padding from sliding around, ensuring stable and consistent wrist support during extended computer sessions.
- 【Better Experience & Pain Relief】Our keyboard arm rest is beneficial to alleviate the soreness caused by direct contact and friction between your arm and a hard desk surface, reducing the risk of wrist fatigue or carpal tunnel. The soft texture of memory foam can evenly distribute the pressure around your wrists and provide good support with just enough give.
- 【Helpful in Multiple Scenarios】Whether you're working, studying, writing, typing, gaming, this keyboard and mouse rest combo is an essential accessory to add comfort and support to your hands and wrists. It’s also a great gift for men, women, family, friend, coworker, gamer, teacher, etc.
FDA product classification also describes a class II 510(k) gene-expression system for distant-recurrence risk in stage I or II, node-negative tumors smaller than 5 cm, used by physicians together with other factors. That description is not interchangeable with the indications for MRI- or pathology-based AI tools.
The practical comparison is not “AI versus genes” in the abstract. Ask how each option fits the specific decision:
- Population match: Does the test cover your stage, receptor status, nodal status, sex, and tumor type?
- Input availability: Is suitable MRI, digitized pathology, or preserved tumor tissue available, and is the sample adequate?
- Endpoint: Does the result estimate recurrence-free survival, distant metastasis, or another outcome relevant to the decision?
- Validation: Was the evidence retrospective or prospective, single-center or multi-institutional, and does it include patients like you?
- Workflow: How is the test ordered, who reviews it, and when will the result arrive relative to treatment planning?
- Utility: Is there evidence that acting on the result improves outcomes, or does it currently provide additional risk information only?
An oncologist may recommend one test, another test, or no additional test depending on the clinical question. An FDA-cleared AI score does not by itself make a genomic assay unnecessary.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Can an AI score tell you to skip chemotherapy?
No. Clearance does not authorize a patient to skip chemotherapy, endocrine therapy, radiation, surgery, or surveillance. A score can be one input in a shared decision, but treatment recommendations require the complete clinical picture.
Before acting on a result, confirm:
- the exact device name and the indication under which it was cleared;
- that your cancer matches the labeled stage, receptor status, and disease type;
- which images, pathology data, or clinical variables were analyzed;
- whether the reported endpoint is the outcome you are trying to understand;
- how the score changes, or does not change, the options your oncology team is considering;
- whether a genomic assay or another established tool addresses the same decision more directly.
Questions to take to your oncology appointment
- Is this result from a specific FDA-cleared device, and does my diagnosis fall within its labeled indication?
- What does the score estimate—recurrence-free survival, distant metastasis, or something else—and over what time period?
- Is the number an absolute risk estimate, a relative risk comparison, or a category derived from a score?
- Which parts of my stage, grade, biomarkers, lymph-node status, and treatment history were included?
- Was this tool validated in patients with characteristics like mine?
- Would the result change a treatment decision, or does it mainly add information to a decision already made?
- How does this result compare with an appropriate genomic assay, if one is available for my situation?
- What are the consequences of treating as high risk or low risk if the estimate is wrong?
Common mistakes when reading “FDA-cleared AI”
Assuming clearance means universal accuracy
Clearance is limited to the labeled use. A model cleared for adult women with HR-positive, HER2-negative stage I–IIIA disease should not automatically be applied to other receptor profiles, stages, sexes, or cancer types.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Confusing prognosis with diagnosis
A recurrence-risk score does not detect a current recurrence and does not replace imaging, pathology review, or clinical examination when those are indicated.
Best Value
- 【No Drill Mounted】Cable management tray can be assembled in as little as 3 minutes or less-simply. Side clips easily clampe the edge of desk, pass through the holes on the sides, and secure excess cables with baskets. Desk cable management supports inward or outward installation to meet your needs in different scenarios, and provides you with great convenience when collecting and organizing wires.
- 【Rubber Pad Protects Desk】Wire organizer under desk built-in soft rubber pads on the clamp protect your desk from scratches, so you will not damage your furniture or office.
- 【Sturdy and Beautiful】Cord management under desk is made of high-quality carbon steel and holds about 15 lbs. The wire basket has 2 holes on each side of the tray to enable your cables to pass freely. Cable baskets are suitable for desk thickness use from 0.4" to 2.4".
- 【Space Saving & Keep Organized】Desk cable management tray holds all your power cords, outlet strips, USB hubs and computer transformers hidden from your feet, and the data cables will not enter the vacuum cleaner to keep your desk clean and tidy. Desk wire organizer is also suitable for use in the kitchen and outdoors.
- 【Reduce Safety Risks】Cable tray under desk keeps all plugs away from your kids, no more worry about tripping. Using 2 holes wire tray saves extra space, helps you easily cabling and wire protection. The mesh design is not easy to accumulate dust, but avoids safety accidents caused by messy wires.
Treating different endpoints as interchangeable
Recurrence-free survival and distant-metastasis risk are related but not identical outcomes. A tool validated for one endpoint cannot be assumed to answer the other.
Overlooking validation design
A blinded, prospectively designed retrospective validation can provide useful evidence of performance, but it remains retrospective. Cohort composition, follow-up, missing data, and calibration all affect how confidently results transfer to a new patient or health system.
Turning a group estimate into an individual guarantee
Even a well-calibrated model gives a probability, not certainty. A low score cannot rule out recurrence, and a high score cannot establish that recurrence is inevitable.
The practical bottom line for patients
FDA clearance means a named AI device is authorized for a defined use after review under a particular regulatory pathway. For 510(k) devices, that review centers on substantial equivalence and supporting safety and performance information. It does not certify a universal breast-cancer prediction engine, prove that treatment changes based on the score improve survival, or eliminate the need for an oncologist’s judgment.
TumorSight Risk and ArteraAI Breast illustrate why the details matter: they analyze different inputs, cover overlapping but not identical populations, and report different endpoints. Use the exact indication and evidence for the device you are offered, then weigh its result with tumor biology, stage, treatment history, established tests, and your preferences.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
